TMCnet News
Research and Markets: 2014 Report on the US Predictive Breast Cancer Gene Testing IndustryDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/m72m99/medipoint) has announced the addition of the "2014 Report on the US Predictive Breast Cancer Gene Testing Industry" report to their offering. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in the US, dominated by Myriad Genetics. Gene testing in Europe is mostly carried out by the state funded health sector, but increasingly private companies are offering breast cancer gene tests to physicians. Myriad Genetics' position in the market is dependent on it being the leading provider of the most common breast cancer mutation. Scope
Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Disease Overview 4 Competitive Assessment 5 Unmet Needs 6 Pipeline Products 7 Industry Overview 8 Current and Future Players 9 Market Drivers, Opportunities and Barriers 10 US Outlook and Forecasts 11 Appendix Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/m72m99/medipoint
|